Breadth of Noven’s Claims to “Transdermal” Drug Delivery System Leads to Holding of Invalidity Under § 112
Judge Stark of the District of Delaware invalidated three Noven patents directed to its Minivelle estrogen therapy patch under § 112, finding that each claim failed to enable and provide written description support for the full scope of the claim. Noven Pharms., Inc. v. Amneal Pharms. LLC, No. 18-699 (D. Del. 2020). Noven’s Minivelle product,…